A retrospective study of comparison between pembrolizumab monotherpay and pembrolizumab with chemotherapy in Non-small cell lung cancer patients
Latest Information Update: 16 Jun 2020
At a glance
- Drugs Pembrolizumab (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology